Insights from BCC Research

What is Synthetic Biology?

Posted by John Bergin on Jul 13, 2018 10:00:00 AM

Synthetic_BiologyThe following is an excerpt from BCC Research Report “Synthetic Biology: Global Markets” by John Bergin.

Read More

Topics: Life Sciences, Biotechnology

This Pill Swallowing You? (Part Two)

Posted by Chris Spivey on Jun 11, 2018 8:46:00 AM

Pharmaceutical Drug

It is now normal to call biotech and small pharma the innovation engines for the pharmaceutical industry. IPO and ICOs abound, as dollars from venture capital truly flood the ecosystem. In 2018, biopharma investment is having a moment. Any big fluctuation, even a positive one, makes stakeholders nervous. Some of the investors might be tourists—Amazon, Google, Apple, IBM, JP Morgan, Berkshire Hathaway and a half dozen others are new entrants, whose long term goals remain unclear. Particularly disturbing are the health insurance and supply chain changes that make headlines, such as this one.

Read More

Topics: Life Sciences, Pharmaceuticals

This Pill Swallowing You?

Posted by Chris Spivey on Jun 4, 2018 12:04:00 PM

Pill

Urgency for an Antidote to Elephantitis

Read More

Topics: Life Sciences, Pharmaceuticals

Universal Flu Vaccines: What Are the Chances?

Posted by BCC Research Editorial on Apr 27, 2018 9:05:00 AM

 

Universal_Flue_Vaccine

With each flu season comes a new flu vaccine, but could this cycle be broken? According to a recent article in Scientific American, scientists are moving closer to a universal flu vaccine. Researchers at the University of Southern California are departing from the traditional vaccine, which relies on a cocktail consisting of several strains of killed virus.

“The new vaccine, by contrast, uses a live virus, so it elicits both an antibody response and T cell immunity—at least in lab ferrets and mice,” the article notes.

Read More

Topics: Life Sciences